Why the study?
Although abnormal PTFV1 is a suggested predictor of adverse cardiovascular events, its performance in patients with CAD remained unknown.
Does abnormal PTFV1 predict a composite of cardiac death and heart failure hospitalization in patients with CAD undergoing PCI?
Population
3,147 patients with CAD who underwent PCI
Comparison
Abnormal PTFV1 vs normal PTFV1
Design
Retrospective cohort study
Follow-up
Median of 5.2 years
Authors
Loading...
PTFV1 may aid post-PCI risk stratification in CAD; leaves open incremental value and requires prospective validation.
Does abnormal PTFV1 predict a composite of cardiac death and heart failure hospitalization in patients with CAD undergoing PCI?
Hirose et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: